The tariff classification of Hydroxyprogesterone Caproate Injection in dosage form, from Spain
Reasoning
The tariff classification of Hydroxyprogesterone Caproate Injection in dosage form, from Spain
Cite this ruling
CBP Ruling N301133 (3004390050): The tariff classification of Hydroxyprogesterone Caproate Injection in dosage form, from Spain
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification of Pramlintide Acetate (CAS-151126-32-8), imported in bulk form; and SYMLIN™ (pramlintide acetate), put up in 1.5 mL glass cartridges and 5 mL vials
The tariff classification of MYOTROPHIN® (mecasermin [recombinant DNA origin]) Injection, imported put up in single-dose vials; MYOTROPHIN® Injection, imported in bulk form; and Mecasermin (human insulin-like growth factor-1, human IGF-1) (CAS-68562-41-4), imported in bulk form, from Taiwan
The tariff classification of Fluticasone Propionate (CAS-80474-14-2), imported in bulk form; and CUTIVATE® Cream, CUTIVATE® Ointment, FLONASE® Nasal Spray, FLOVENT® Inhalation Aerosol, and FLOVENT® ROTADISK®, imported put up in measured doses or in forms or packings for retail sale, from the United Kingdom, France, Italy, Canada, Singapore, etc.
The tariff classification and country of origin marking of LUPRON DEPOT 7.5 mg (leuprolide acetate for depot suspension) prefilled dual-chamber syringe; and the tariff classification of plastic plungers for syringes from Japan
The tariff classification of recombinant human interferonbeta, in bulk form and put up in measured doses, from the UnitedKingdom